Tissue penetration of antimicrobials: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 283: Line 283:
*† if inflammation present
*† if inflammation present


== Specific Tissues ==
==Prostate==

===Prostate===


*Poorly penetrated by most antibiotics
*Poorly penetrated by most antibiotics
Line 293: Line 295:
*[[Piperacillin]], [[aztreonam]], [[imipenem]], and some [[aminoglycosides]] are likely useful
*[[Piperacillin]], [[aztreonam]], [[imipenem]], and some [[aminoglycosides]] are likely useful


==Bone==
===Bone===


*Essentially all antibiotics achieve similar bone-to-serum levels, with the exception of oral β-lactams which nevertheless have no worse outcomes[[CiteRef::landersdorfer2009pe]]
*Essentially all antibiotics achieve similar bone-to-serum levels, with the exception of oral β-lactams which nevertheless have no worse outcomes[[CiteRef::landersdorfer2009pe]]


=== Eye ===

* Ocular compartments include anterior and posterior
** Anterior includes aqeous humour, and is best accessed using topical medications
** Posterior includes vitreous humour, retina, and choroid, and is best accessed using intravitreal or systemic medications
* Penetration of systemic antimicrobials into retina and vitreous is poor (~0 to 2%), but is better with inflammation[[CiteRef::brockhaus2019re]]

{| class="wikitable"
!Class
!Antimicrobial
!Vitreal Penetration
|-
| rowspan="3" |penicillins
|[[ampicillin]]
|below MIC in non-inflamed rabbit eyes
|-
|[[amoxicillin]]
|2% (below MIC) in non-inflamed rabbit eyes
|-
|[[piperacillin]]
|undetectable in inflamed human eyes
|-
| rowspan="4" |cephalosporins
|[[cefazolin]]
|above MIC in inflamed rabbit eyes
|-
|[[ceftriaxone]]
|4% in non-inflamed human eyes
|-
|[[ceftazidime]]
|30% in inflamed rabbit eyes
|-
|[[cefipime]]
|8% in non-inflamed human eyes
|-
| rowspan="2" |carbapenems
|[[imipenem]]
|8 to 10% in non-inflamed human eyes
|-
|[[meropenem]]
|30% in non-inflamed human eyes
|-
|oxazolidinones
|[[linezolid]]
|30 to 80% in non-inflamed human eyes
|-
|
|[[vancomycin]]
|above MIC in inflamed rabbit eyes
|-
|
|[[daptomycin]]
|30% in inflamed human eyes
|-
| rowspan="2" |aminoglycosides
|[[amikacin]]
|below MIC in inflamed rabbit eyes
|-
|[[gentamicin]]
|below MIC in inflamed rabbit eyes
|-
| rowspan="3" |fluoroquinolones
|[[ciprofloxacin]]
|below MIC in non-inflamed human eyes
|-
|[[levofloxacin]]
|30% but below MIC in non-inflamed human eyes
|-
|[[moxifloxacin]]
|10 to 40% and above MIC in non-inflamed human eyes
|}
[[Category:Antimicrobials]]
[[Category:Antimicrobials]]

Revision as of 14:58, 6 March 2021

Summary

Class Antimicrobial Blood CNS Vitreous Urine Prostate Necrotic
Antibiotics: β-Lactams
Penicillins β-lactamase inhibitors
ampicillin +
piperacillin-tazobactam +†
Cephalosporins first-generation cephalosporins
second-generation cephalosporins
third-generation cephalosporins +†
cefepime +
ceftazidime + +
Cephamycins cephamycins
cefoxitin
Carbapenems imipenem +
Antibiotics: Non-β-Lactams
Aminoglycosides
Chloramphenicol chloramphenicol +
Fluoroquinolones –? + +
Fosfomycin fosfomycin +
Lincosamides clindamycin +
Lipopeptides daptomycin + +
Macrolides macrolides +
Nitrofurans nitrofurantoin +
Nitroimidazoles metronidazole +
Rifamycins rifampin +
Sulfonamides trimethoprim-sulfamethoxazole +
Tetracyclines tetracyclines +
doxycycline + +
Antivirals
acyclovir / valacyclovir +
ganciclovir +
foscarnet
Antifungals
Azoles fluconazole +
Echinocandins +
Class Antimicrobial Blood CNS Urine Prostate Necrotic
  • † if inflammation present

Specific Tissues

Prostate

  • Poorly penetrated by most antibiotics
  • Penetration is higher with a high concentration gradient, high lipid solubility, low degree of ionization, high dissociation constant, low protein binding, and small molecular size
  • Fluoroquinolones are the mainstay of therapy, though there is increasing resistance
  • TMP-SMX often used, though conflicting data about its penetration into the prostate
  • Minocycline, doxycycline, and macrolides achieve high levels in the prostate but are rarely indicated for the causative organisms
  • Third-generation cephalosporins and carbapenems can be used
  • Piperacillin, aztreonam, imipenem, and some aminoglycosides are likely useful

Bone

  • Essentially all antibiotics achieve similar bone-to-serum levels, with the exception of oral β-lactams which nevertheless have no worse outcomes1

Eye

  • Ocular compartments include anterior and posterior
    • Anterior includes aqeous humour, and is best accessed using topical medications
    • Posterior includes vitreous humour, retina, and choroid, and is best accessed using intravitreal or systemic medications
  • Penetration of systemic antimicrobials into retina and vitreous is poor (~0 to 2%), but is better with inflammation2
Class Antimicrobial Vitreal Penetration
penicillins ampicillin below MIC in non-inflamed rabbit eyes
amoxicillin 2% (below MIC) in non-inflamed rabbit eyes
piperacillin undetectable in inflamed human eyes
cephalosporins cefazolin above MIC in inflamed rabbit eyes
ceftriaxone 4% in non-inflamed human eyes
ceftazidime 30% in inflamed rabbit eyes
cefipime 8% in non-inflamed human eyes
carbapenems imipenem 8 to 10% in non-inflamed human eyes
meropenem 30% in non-inflamed human eyes
oxazolidinones linezolid 30 to 80% in non-inflamed human eyes
vancomycin above MIC in inflamed rabbit eyes
daptomycin 30% in inflamed human eyes
aminoglycosides amikacin below MIC in inflamed rabbit eyes
gentamicin below MIC in inflamed rabbit eyes
fluoroquinolones ciprofloxacin below MIC in non-inflamed human eyes
levofloxacin 30% but below MIC in non-inflamed human eyes
moxifloxacin 10 to 40% and above MIC in non-inflamed human eyes

References

  1. ^  Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
  2. ^  L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.